Search

everythinglearnresearchcommunity

for

Search:↓

Certain herbal compounds might help prevent hair loss in menopausal women by activating Vitamin D receptors.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

D-004 shows moderate antidepressant effects but is less effective than Sertraline and Imipramine.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Itraconazole effectively treated a woman's painful skin condition and hair loss.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Some birth control pills have a higher risk of blood clots than others.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Retinoids are effective for skin conditions like severe acne and psoriasis but must be used with caution due to potential side effects and risks during pregnancy.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Surgery may be needed for resistant thyrotoxicosis.

During late pregnancy in rats, hormonal changes increased certain GABAA receptors in specific brain cells.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

Two new compounds were found to effectively reduce hair growth in mice.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

Agomelatine might help reduce hair loss caused by valproate.

Lugol's solution can cause thyroid problems if used long-term for non-approved reasons.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Rheumatology clinics should always provide preconception counseling for women on DMARDs.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

OCT binds strongly to hair sheath cells and may affect skin and hair growth with fewer side effects than vitamin D3.